Explore
Medicinehospital

Degarelix

Hormone-blocking injection (GnRH antagonist) for advanced prostate cancer.

Clinical information

Common uses

  • advanced prostate cancer

Common side effects

  • injection site pain, redness or swelling
  • hot flashes
  • raised liver enzymes

Cautions

  • severe allergic reactions including anaphylaxis reported
  • may prolong the heart's QT interval
  • caution with severe liver or kidney problems

Pregnancy: not for use in women — can harm an unborn baby

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, Firmagon (degarelix) label, setid ab11dd8a-0fd9-4013-89ab-e114557c7e4b (accessed 2026-08-16)

Approved brands & formulations1

Brand nameDosage formStrengthImporterCategory
DegarelixParenteral ( Powder for injection )80mgMFDA designated importers with Pre Authorization approval before importhospital
Old search API